Exploring the Benefits of Pelvic Floor Muscle Training on Bladder, Bowel, and Sexual Function in People with Spinal Cord Injury
Exploring the Feasibility and Urogenital Benefits of Pelvic Floor Muscle Training in Individuals with Motor-incomplete Spinal Cord Injury
2 other identifiers
interventional
30
1 country
1
Brief Summary
The goal of this trial is to learn about the feasibility and benefits of delivering a pelvic floor muscle training program to people with motor-incomplete spinal cord injury. The main questions it aims to answer are:
- 1.To evaluate the feasibility of delivering a pelvic floor muscle training program to people with spinal cord injury. The investigators will examine recruitment rate, compliance and adherence to the intervention and other study protocols, adverse events, and participant perspectives of the study protocols.
- 2.To explore the potential effectiveness of pelvic floor muscle training on pelvic floor, bladder, bowel, and sexual function.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2025
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 18, 2024
CompletedFirst Posted
Study publicly available on registry
November 26, 2024
CompletedStudy Start
First participant enrolled
March 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
March 31, 2027
March 7, 2025
March 1, 2025
2.1 years
November 18, 2024
March 4, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Feasibility - Recruitment Rate
Recruitment rate will be evaluated by number of participants approached, screened for eligibility, as well as reasons for exclusions.
Through study completion, up to 12 weeks
Feasibility - Compliance
Compliance will be tracked by the adherence of participants to the prescribed exercise program, with reasons for missed sessions or drop-outs noted.
Through study completion, up to 12 weeks
Feasibility - Adverse Events
Any adverse events to study protocols will be recorded.
Through study completion, up to 12 weeks
Feasibility - Acceptability
The acceptability of the intervention will be evaluated using a 7-point Likert scale to rate participants' enjoyment of the exercise program and whether they felt the program was beneficial for improving their bladder, bowel, and/or sexual function.
Through study completion, up to 12 weeks
Secondary Outcomes (13)
Incontinence Quality of Life Questionnaire (I-QoL)
From enrollment to within 2 weeks of completing the study intervention
Neurogenic Bladder Symptoms Score (NBSS)
From enrollment to within 2 weeks of completing the study intervention
3-Day Bladder Diary
From enrollment to within 2 weeks of completing the study intervention
Timed Bowel Movement
From enrollment to within 2 weeks of completing the study intervention
Neurogenic Bowel Dysfunction Score (NBDS)
From enrollment to within 2 weeks of completing the study intervention
- +8 more secondary outcomes
Study Arms (1)
Pelvic Floor Muscle Training Group
EXPERIMENTALInterventions
Pelvic floor muscle training 5x/week for 12-weeks
Eligibility Criteria
You may qualify if:
- Are at least 19 years of age.
- Have a non-progressive, motor-incomplete spinal cord injury that is at or above the T12 neurological level at least 12 months ago.
- Have symptoms of bladder, bowel, and/or sexual dysfunction that are caused by your spinal cord injury.
- Have stable management of spinal cord related secondary health concerns (e.g., spasticity, neuropathic pain).
- Are able to speak and understand English.
You may not qualify if:
- Are currently pregnant, have been pregnant within the past 6 months, or are planning to become pregnant in the next 6 months.
- Have had urogenital surgery within the past 12 months.
- Have received Botox bladder injections within the past 4 weeks, or anticipate receiving an injection in the next 6 months.
- Have presence of severe medical issue that in the investigator's judgement would adversely affect the participant's participation in the study. Examples include, but are not limited to pressure sores, cardiovascular disease, and unmanaged diabetes.
- Have any permanent metal fixtures in their head (excluding dental fillings), or pacemakers, stimulators, or implanted medication pumps.
- Have a history of seizures, are taking medications that lower the seizure threshold, or experience recurring headaches.
- Have a condition for which exercise is contraindicated.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Blusson Spinal Cord Centre
Vancouver, British Columbia, V5Z1M9, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Tania Lam, PhD, PT
University of British Columbia, ICORD
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
November 18, 2024
First Posted
November 26, 2024
Study Start
March 1, 2025
Primary Completion (Estimated)
March 31, 2027
Study Completion (Estimated)
March 31, 2027
Last Updated
March 7, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will not share